Inventor

Emi Hosaka

Inventor
Machida, JP

Overview

40→
Patents
2005–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 40 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary
C07KPeptides22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture16%
A61KPreparations for medical, dental or toiletry purposes11%
G01NInvestigating or analysing materials by determining their chemical or physical properties11%
C12NMicroorganisms or enzymes9%
C12YEnzymes9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,590,203Human CDR-grafted antibody and antibody fragment thereof202010,233,475Antibody composition-producing cell201910,233,247Method of modulating the activity of functional immune molecules201910,131,711Human CDR-grafted antibody and antibody fragment thereof20189,637,545'Method of modulating the activity of functional immune molecules'20179,409,982'Antibody composition-producing cell'20169,051,371'Human CDR-grafted antibody and antibody fragment thereof'20158,900,584'Human CDR-grafted antibody and antibody fragment thereof'20148,895,266'Antibody composition-producing cell'20148,679,491'Method of modulating the activity of functional immune molecules'20148,367,407'Cells with altered fucosylation and producing antibodies therefrom'20138,329,443'Antibody composition-producing cell'20128,158,760'Glycoengineered, recombinant antibody'20128,143,058'Human CDR-grafted antibody and antibody fragment thereof'20128,110,195'Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody'20128,101,185'Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylation'20128,093,361'Anti-perp antibody'20128,093,362'Anti-PERP recombinant antibody'20128,067,232'Antibody composition-producing cell with inactivated A-1,6-fusocyltransferase'20118,039,595'Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylation'20117,846,725'Antibody composition-producing cell in which enzyme expression is inhibited by RNAi'20107,842,797'Human CDR-grafted antibody and antibody fragment thereof'20107,763,246'Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor'20107,741,442'Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation'20107,737,325'Antibody composition-producing cell'20107,718,175'Method of modulating the activity of functional immune molecules to interleukin-5 receptor protein'20107,708,992'Methods for producing antibody compositions with increased ADCC'20107,708,997'Method of modulating the activity of functional immune molecules'20107,687,061'Method of modulating the activity of functional immune molecules to Her-2'20107,682,610'Method of modulating the activity of functional immune molecules'20107,682,611'Method of modulating the activity of functional immune molecules to CXCR4 protein'20107,655,228'Method of modulating the activity of functional immune molecules to GM2'20107,651,688'Method of modulating the activity of functional immune molecules to CD52'20107,504,104'Human CDR-grafted antibody and antibody fragment thereof'20097,425,446'Antibody composition-producing cell'20087,404,953'Methods using eosinophil-specific apoptosis inducer'20087,393,683'Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferase'20087,214,775'Method of modulating the activity of functional immune molecules'20077,064,191'Process for purifying antibody'20066,946,292'Cells producing antibody compositions with increased antibody dependent cytotoxic activity'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2020Based in Machida, JP· patent location history
2008Based in Tokyo, JP· patent location history
2010–2020Patents assigned to KYOWA HAKKO KIRIN CO LTD (32)· patent assignee history
2011–2014Patents assigned to HOSAKA EMI (10)· patent assignee history
2011–2014Patents assigned to NAKAMURA KAZUYASU (9)· patent assignee history
2011–2014Patents assigned to HANAI NOBUO (7)· patent assignee history
2011–2014Patents assigned to KANDA YUTAKA (7)· patent assignee history
2012Based in Chiyoda-ku, JP· patent location history
2012Based in Stuttgart, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
KYOWA HAKKO KIRIN CO LTD322010–2020
HOSAKA EMIself102011–2014
NAKAMURA KAZUYASU92011–2014
HANAI NOBUO72011–2014
KANDA YUTAKA72011–2014
Locations
LocationPatentsSpan
Machida, JP352005–2020
Chiyoda-ku, JP22012
Stuttgart, DE22012
Tokyo, JP12008